APO Research
Talk to an analyst

APO RESEARCH · REPORT

Famotidine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Famotidine Market Analysis and Forecast 2026-2032

22 December 2025208 pages

Choose your research edition.

Industry ResearchFamotidine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Famotidine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Famotidine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Famotidine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Famotidine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Famotidine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Famotidine's global sales reached XX (K Units) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned UQUIFA as the global sales leader, a title it has maintained for several consecutive years. Notably, UQUIFA's performance in primary markets is also remarkable. In the Chinese market, sales were XX (K Units), a change of XX% from the previous year. In Europe, sales were XX (K Units), showing a year-on-year of XX%. In the US, sales were XX (K Units), a year-on-year change of XX%.

The major global manufacturers in the Famotidine market include UQUIFA, Rakshit Drug, Phalanx Labs, PAT IMPEX, Jayusion, Gauri Fine Chemicals, Darou Pakhsh Pharma Chem and Chempro Pharma, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Famotidine production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Famotidine by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Famotidine, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Famotidine, also provides the consumption of main regions and countries. Of the upcoming market potential for Famotidine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Famotidine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Famotidine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Famotidine sales, projected growth trends, production technology, application and end-user industry.

Famotidine Segment by Company

UQUIFA

Rakshit Drug

Phalanx Labs

PAT IMPEX

Jayusion

Gauri Fine Chemicals

Darou Pakhsh Pharma Chem

Chempro Pharma

Famotidine Segment by Type

Tablets

Injection

Famotidine Segment by Application

Hospital

Clinic

Other

Famotidine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famotidine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Famotidine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famotidine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Famotidine production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Famotidine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Famotidine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Famotidine sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Famotidine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablets Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Famotidine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Famotidine Industry Trends Table 9. Famotidine Industry Drivers Table 10. Famotidine Industry Opportunities and Challenges Table 11. Famotidine Industry Restraints Table 12. Global Famotidine Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 13. Global Famotidine Production by Region (2021-2026) & (K Units) Table 14. Global Famotidine Production by Region (2027-2032) & (K Units) Table 15. Global Famotidine Production Market Share by Region (2021-2026) Table 16. Global Famotidine Production Market Share by Region (2027-2032) Table 17. Global Famotidine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Famotidine Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Famotidine Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Famotidine Revenue Market Share by Region (2021-2026) Table 21. Global Famotidine Revenue Market Share by Region (2027-2032) Table 22. Global Famotidine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Famotidine Sales by Region (2021-2026) & (K Units) Table 24. Global Famotidine Sales by Region (2027-2032) & (K Units) Table 25. Global Famotidine Sales Market Share by Region (2021-2026) Table 26. Global Famotidine Sales Market Share by Region (2027-2032) Table 27. Global Famotidine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Famotidine Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Famotidine Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Famotidine Sales Market Share by Manufacturers (2021-2026) Table 31. Global Famotidine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 32. Global Famotidine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Famotidine Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Famotidine Manufacturers, Product Type & Application Table 35. Global Famotidine Manufacturers Commercialization Time Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Famotidine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 38. Global Famotidine Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Famotidine Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Famotidine Revenue Market Share by Type (2021-2026) Table 41. Global Famotidine Revenue Market Share by Type (2027-2032) Table 42. Global Famotidine Sales by Type (2021-2026) & (K Units) Table 43. Global Famotidine Sales by Type (2027-2032) & (K Units) Table 44. Global Famotidine Sales Market Share by Type (2021-2026) Table 45. Global Famotidine Sales Market Share by Type (2027-2032) Table 46. Global Famotidine Price by Type (2021-2026) & (US$/unit) Table 47. Global Famotidine Price by Type (2027-2032) & (US$/unit) Table 48. Global Famotidine Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Famotidine Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Famotidine Revenue Market Share by Application (2021-2026) Table 51. Global Famotidine Revenue Market Share by Application (2027-2032) Table 52. Global Famotidine Sales by Application (2021-2026) & (K Units) Table 53. Global Famotidine Sales by Application (2027-2032) & (K Units) Table 54. Global Famotidine Sales Market Share by Application (2021-2026) Table 55. Global Famotidine Sales Market Share by Application (2027-2032) Table 56. Global Famotidine Price by Application (2021-2026) & (US$/unit) Table 57. Global Famotidine Price by Application (2027-2032) & (US$/unit) Table 58. UQUIFA Company Information Table 59. UQUIFA Business Overview Table 60. UQUIFA Famotidine Sales (K Units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. UQUIFA Famotidine Product Portfolio Table 62. UQUIFA Recent Development Table 63. Rakshit Drug Company Information Table 64. Rakshit Drug Business Overview Table 65. Rakshit Drug Famotidine Sales (K Units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Rakshit Drug Famotidine Product Portfolio Table 67. Rakshit Drug Recent Development Table 68. Phalanx Labs Company Information Table 69. Phalanx Labs Business Overview Table 70. Phalanx Labs Famotidine Sales (K Units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Phalanx Labs Famotidine Product Portfolio Table 72. Phalanx Labs Recent Development Table 73. PAT IMPEX Company Information Table 74. PAT IMPEX Business Overview Table 75. PAT IMPEX Famotidine Sales (K Units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. PAT IMPEX Famotidine Product Portfolio Table 77. PAT IMPEX Recent Development Table 78. Jayusion Company Information Table 79. Jayusion Business Overview Table 80. Jayusion Famotidine Sales (K Units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Jayusion Famotidine Product Portfolio Table 82. Jayusion Recent Development Table 83. Gauri Fine Chemicals Company Information Table 84. Gauri Fine Chemicals Business Overview Table 85. Gauri Fine Chemicals Famotidine Sales (K Units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Gauri Fine Chemicals Famotidine Product Portfolio Table 87. Gauri Fine Chemicals Recent Development Table 88. Darou Pakhsh Pharma Chem Company Information Table 89. Darou Pakhsh Pharma Chem Business Overview Table 90. Darou Pakhsh Pharma Chem Famotidine Sales (K Units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Darou Pakhsh Pharma Chem Famotidine Product Portfolio Table 92. Darou Pakhsh Pharma Chem Recent Development Table 93. Chempro Pharma Company Information Table 94. Chempro Pharma Business Overview Table 95. Chempro Pharma Famotidine Sales (K Units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Chempro Pharma Famotidine Product Portfolio Table 97. Chempro Pharma Recent Development Table 98. North America Famotidine Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Famotidine Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Famotidine Sales by Type (2021-2026) & (K Units) Table 101. North America Famotidine Sales by Type (2027-2032) & (K Units) Table 102. North America Famotidine Sales Price by Type (2021-2026) & (US$/unit) Table 103. North America Famotidine Sales Price by Type (2027-2032) & (US$/unit) Table 104. North America Famotidine Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Famotidine Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Famotidine Sales by Application (2021-2026) & (K Units) Table 107. North America Famotidine Sales by Application (2027-2032) & (K Units) Table 108. North America Famotidine Sales Price by Application (2021-2026) & (US$/unit) Table 109. North America Famotidine Sales Price by Application (2027-2032) & (US$/unit) Table 110. North America Famotidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Famotidine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Famotidine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Famotidine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 114. North America Famotidine Sales by Country (2021-2026) & (K Units) Table 115. North America Famotidine Sales by Country (2027-2032) & (K Units) Table 116. North America Famotidine Sales Price by Country (2021-2026) & (US$/unit) Table 117. North America Famotidine Sales Price by Country (2027-2032) & (US$/unit) Table 118. United States Famotidine Revenue (2021-2032) & (US$ Million) Table 119. Canada Famotidine Revenue (2021-2032) & (US$ Million) Table 120. Mexico Famotidine Revenue (2021-2032) & (US$ Million) Table 121. Europe Famotidine Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Famotidine Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Famotidine Sales by Type (2021-2026) & (K Units) Table 124. Europe Famotidine Sales by Type (2027-2032) & (K Units) Table 125. Europe Famotidine Sales Price by Type (2021-2026) & (US$/unit) Table 126. Europe Famotidine Sales Price by Type (2027-2032) & (US$/unit) Table 127. Europe Famotidine Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Famotidine Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Famotidine Sales by Application (2021-2026) & (K Units) Table 130. Europe Famotidine Sales by Application (2027-2032) & (K Units) Table 131. Europe Famotidine Sales Price by Application (2021-2026) & (US$/unit) Table 132. Europe Famotidine Sales Price by Application (2027-2032) & (US$/unit) Table 133. Europe Famotidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Famotidine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Famotidine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Famotidine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 137. Europe Famotidine Sales by Country (2021-2026) & (K Units) Table 138. Europe Famotidine Sales by Country (2027-2032) & (K Units) Table 139. Europe Famotidine Sales Price by Country (2021-2026) & (US$/unit) Table 140. Europe Famotidine Sales Price by Country (2027-2032) & (US$/unit) Table 141. Germany Famotidine Revenue (2021-2032) & (US$ Million) Table 142. France Famotidine Revenue (2021-2032) & (US$ Million) Table 143. U.K. Famotidine Revenue (2021-2032) & (US$ Million) Table 144. Italy Famotidine Revenue (2021-2032) & (US$ Million) Table 145. Russia Famotidine Revenue (2021-2032) & (US$ Million) Table 146. Spain Famotidine Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Famotidine Revenue (2021-2032) & (US$ Million) Table 148. Switzerland Famotidine Revenue (2021-2032) & (US$ Million) Table 149. Sweden Famotidine Revenue (2021-2032) & (US$ Million) Table 150. Poland Famotidine Revenue (2021-2032) & (US$ Million) Table 151. China Famotidine Revenue by Type (2021-2026) & (US$ Million) Table 152. China Famotidine Revenue by Type (2027-2032) & (US$ Million) Table 153. China Famotidine Sales by Type (2021-2026) & (K Units) Table 154. China Famotidine Sales by Type (2027-2032) & (K Units) Table 155. China Famotidine Sales Price by Type (2021-2026) & (US$/unit) Table 156. China Famotidine Sales Price by Type (2027-2032) & (US$/unit) Table 157. China Famotidine Revenue by Application (2021-2026) & (US$ Million) Table 158. China Famotidine Revenue by Application (2027-2032) & (US$ Million) Table 159. China Famotidine Sales by Application (2021-2026) & (K Units) Table 160. China Famotidine Sales by Application (2027-2032) & (K Units) Table 161. China Famotidine Sales Price by Application (2021-2026) & (US$/unit) Table 162. China Famotidine Sales Price by Application (2027-2032) & (US$/unit) Table 163. Asia Famotidine Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Famotidine Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Famotidine Sales by Type (2021-2026) & (K Units) Table 166. Asia Famotidine Sales by Type (2027-2032) & (K Units) Table 167. Asia Famotidine Sales Price by Type (2021-2026) & (US$/unit) Table 168. Asia Famotidine Sales Price by Type (2027-2032) & (US$/unit) Table 169. Asia Famotidine Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Famotidine Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Famotidine Sales by Application (2021-2026) & (K Units) Table 172. Asia Famotidine Sales by Application (2027-2032) & (K Units) Table 173. Asia Famotidine Sales Price by Application (2021-2026) & (US$/unit) Table 174. Asia Famotidine Sales Price by Application (2027-2032) & (US$/unit) Table 175. Asia Famotidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Famotidine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Famotidine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Famotidine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. Asia Famotidine Sales by Country (2021-2026) & (K Units) Table 180. Asia Famotidine Sales by Country (2027-2032) & (K Units) Table 181. Asia Famotidine Sales Price by Country (2021-2026) & (US$/unit) Table 182. Asia Famotidine Sales Price by Country (2027-2032) & (US$/unit) Table 183. Japan Famotidine Revenue (2021-2032) & (US$ Million) Table 184. South Korea Famotidine Revenue (2021-2032) & (US$ Million) Table 185. India Famotidine Revenue (2021-2032) & (US$ Million) Table 186. Australia Famotidine Revenue (2021-2032) & (US$ Million) Table 187. Taiwan Famotidine Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Famotidine Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Famotidine Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Famotidine Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Famotidine Sales by Type (2021-2026) & (K Units) Table 192. SAMEA Famotidine Sales by Type (2027-2032) & (K Units) Table 193. SAMEA Famotidine Sales Price by Type (2021-2026) & (US$/unit) Table 194. SAMEA Famotidine Sales Price by Type (2027-2032) & (US$/unit) Table 195. SAMEA Famotidine Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Famotidine Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Famotidine Sales by Application (2021-2026) & (K Units) Table 198. SAMEA Famotidine Sales by Application (2027-2032) & (K Units) Table 199. SAMEA Famotidine Sales Price by Application (2021-2026) & (US$/unit) Table 200. SAMEA Famotidine Sales Price by Application (2027-2032) & (US$/unit) Table 201. SAMEA Famotidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Famotidine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Famotidine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Famotidine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 205. SAMEA Famotidine Sales by Country (2021-2026) & (K Units) Table 206. SAMEA Famotidine Sales by Country (2027-2032) & (K Units) Table 207. SAMEA Famotidine Sales Price by Country (2021-2026) & (US$/unit) Table 208. SAMEA Famotidine Sales Price by Country (2027-2032) & (US$/unit) Table 209. Brazil Famotidine Revenue (2021-2032) & (US$ Million) Table 210. Argentina Famotidine Revenue (2021-2032) & (US$ Million) Table 211. Chile Famotidine Revenue (2021-2032) & (US$ Million) Table 212. Colombia Famotidine Revenue (2021-2032) & (US$ Million) Table 213. Peru Famotidine Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Famotidine Revenue (2021-2032) & (US$ Million) Table 215. Israel Famotidine Revenue (2021-2032) & (US$ Million) Table 216. UAE Famotidine Revenue (2021-2032) & (US$ Million) Table 217. Turkey Famotidine Revenue (2021-2032) & (US$ Million) Table 218. Iran Famotidine Revenue (2021-2032) & (US$ Million) Table 219. Egypt Famotidine Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Famotidine Distributors List Table 223. Famotidine Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Famotidine Product Image Figure 2. Global Famotidine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Famotidine Market Size Share 2021 VS 2025 VS 2032 Figure . Tablets Image Figure 1. Injection Image Figure 2. Global Famotidine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Famotidine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hospital Image Figure 5. Clinic Image Figure 6. Other Image Figure 7. Global Famotidine Capacity, Capacity Utilization (2021-2032) & (K Units) Figure 8. Global Famotidine Production by Region: 2021 VS 2025 VS 2032 (K Units) Figure 9. Global Famotidine Production Market Share by Region: 2025 Versus 2032 Figure 10. Global Famotidine Production Market Share by Region (2021-2032) Figure 11. North America Famotidine Production Growth Rate (2021-2032) & (K Units) Figure 12. Europe Famotidine Production Growth Rate (2021-2032) & (K Units) Figure 13. China Famotidine Production Growth Rate (2021-2032) & (K Units) Figure 14. Japan Famotidine Production Growth Rate (2021-2032) & (K Units) Figure 15. Global Famotidine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Famotidine Revenue (2021-2032) & (US$ Million) Figure 17. Global Famotidine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Famotidine Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Famotidine Revenue Market Share by Region (2021-2032) Figure 20. Global Famotidine Sales (2021-2032) & (K Units) Figure 21. Global Famotidine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Famotidine Sales Market Share by Region (2021-2032) Figure 23. North America Famotidine Sales YoY (2021-2032) & (K Units) Figure 24. Europe Famotidine Sales YoY (2021-2032) & (K Units) Figure 25. China Famotidine Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Famotidine Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Famotidine Sales YoY (2021-2032) & (K Units) Figure 28. Global Famotidine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Famotidine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Famotidine Revenue Market Share by Type (2021-2032) Figure 32. Global Famotidine Sales Market Share by Type (2021-2032) Figure 33. Global Famotidine Revenue Market Share by Application (2021-2032) Figure 34. Global Famotidine Sales Market Share by Application (2021-2032) Figure 35. North America Famotidine Revenue Share by Type (2021-2032) Figure 36. North America Famotidine Sales Share by Type (2021-2032) Figure 37. North America Famotidine Revenue Share by Application (2021-2032) Figure 38. North America Famotidine Sales Share by Application (2021-2032) Figure 39. North America Famotidine Revenue Share by Country (2021-2032) Figure 40. North America Famotidine Sales Share by Country (2021-2032) Figure 41. Europe Famotidine Revenue Share by Type (2021-2032) Figure 42. Europe Famotidine Sales Share by Type (2021-2032) Figure 43. Europe Famotidine Revenue Share by Application (2021-2032) Figure 44. Europe Famotidine Sales Share by Application (2021-2032) Figure 45. Europe Famotidine Revenue Share by Country (2021-2032) Figure 46. Europe Famotidine Sales Share by Country (2021-2032) Figure 47. China Famotidine Revenue Share by Type (2021-2032) Figure 48. China Famotidine Sales Share by Type (2021-2032) Figure 49. China Famotidine Revenue Share by Application (2021-2032) Figure 50. China Famotidine Sales Share by Application (2021-2032) Figure 51. Asia Famotidine Revenue Share by Type (2021-2032) Figure 52. Asia Famotidine Sales Share by Type (2021-2032) Figure 53. Asia Famotidine Revenue Share by Application (2021-2032) Figure 54. Asia Famotidine Sales Share by Application (2021-2032) Figure 55. Asia Famotidine Revenue Share by Country (2021-2032) Figure 56. Asia Famotidine Sales Share by Country (2021-2032) Figure 57. SAMEA Famotidine Revenue Share by Type (2021-2032) Figure 58. SAMEA Famotidine Sales Share by Type (2021-2032) Figure 59. SAMEA Famotidine Revenue Share by Application (2021-2032) Figure 60. SAMEA Famotidine Sales Share by Application (2021-2032) Figure 61. SAMEA Famotidine Revenue Share by Country (2021-2032) Figure 62. SAMEA Famotidine Sales Share by Country (2021-2032) Figure 63. Famotidine Value Chain Figure 64. Manufacturing Cost Structure Figure 65. Famotidine Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Injection
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • UQUIFA
  • Rakshit Drug
  • Phalanx Labs
  • PAT IMPEX
  • Jayusion
  • Gauri Fine Chemicals
  • Darou Pakhsh Pharma Chem
  • Chempro Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Famotidine Market by Type
  3. 1.2.1 Global Famotidine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablets
  5. 1.2.3 Injection
  6. 1.3 Famotidine Market by Application
  7. 1.3.1 Global Famotidine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Famotidine Market Dynamics
  1. 2.1 Famotidine Industry Trends
  2. 2.2 Famotidine Industry Drivers
  3. 2.3 Famotidine Industry Opportunities and Challenges
  4. 2.4 Famotidine Industry Restraints
3 Global Famotidine Production Overview
  1. 3.1 Global Famotidine Production Capacity (2021-2032)
  2. 3.2 Global Famotidine Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Famotidine Production by Region
  4. 3.3.1 Global Famotidine Production by Region (2021-2026)
  5. 3.3.2 Global Famotidine Production by Region (2027-2032)
  6. 3.3.3 Global Famotidine Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Famotidine Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Famotidine Revenue by Region
  3. 4.2.1 Global Famotidine Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Famotidine Revenue by Region (2021-2026)
  5. 4.2.3 Global Famotidine Revenue by Region (2027-2032)
  6. 4.2.4 Global Famotidine Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Famotidine Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Famotidine Sales by Region
  9. 4.4.1 Global Famotidine Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Famotidine Sales by Region (2021-2026)
  11. 4.4.3 Global Famotidine Sales by Region (2027-2032)
  12. 4.4.4 Global Famotidine Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Famotidine Revenue by Manufacturers
  2. 5.1.1 Global Famotidine Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Famotidine Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Famotidine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Famotidine Sales by Manufacturers
  6. 5.2.1 Global Famotidine Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Famotidine Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Famotidine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Famotidine Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Famotidine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Famotidine Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Famotidine Manufacturers, Product Type & Application
  13. 5.7 Global Famotidine Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Famotidine Market CR5 and HHI
  16. 5.8.2 2025 Famotidine Tier 1, Tier 2, and Tier 3
6 Famotidine Market by Type
  1. 6.1 Global Famotidine Revenue by Type
  2. 6.1.1 Global Famotidine Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Famotidine Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Famotidine Sales by Type
  5. 6.2.1 Global Famotidine Sales by Type (2021-2032) & (K Units)
  6. 6.2.2 Global Famotidine Sales Market Share by Type (2021-2032)
  7. 6.3 Global Famotidine Price by Type
7 Famotidine Market by Application
  1. 7.1 Global Famotidine Revenue by Application
  2. 7.1.1 Global Famotidine Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Famotidine Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Famotidine Sales by Application
  5. 7.2.1 Global Famotidine Sales by Application (2021-2032) & (K Units)
  6. 7.2.2 Global Famotidine Sales Market Share by Application (2021-2032)
  7. 7.3 Global Famotidine Price by Application
8 Company Profiles
  1. 8.1 UQUIFA
  2. 8.1.1 UQUIFA Company Information
  3. 8.1.2 UQUIFA Business Overview
  4. 8.1.3 UQUIFA Famotidine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 UQUIFA Famotidine Product Portfolio
  6. 8.1.5 UQUIFA Recent Developments
  7. 8.2 Rakshit Drug
  8. 8.2.1 Rakshit Drug Company Information
  9. 8.2.2 Rakshit Drug Business Overview
  10. 8.2.3 Rakshit Drug Famotidine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Rakshit Drug Famotidine Product Portfolio
  12. 8.2.5 Rakshit Drug Recent Developments
  13. 8.3 Phalanx Labs
  14. 8.3.1 Phalanx Labs Company Information
  15. 8.3.2 Phalanx Labs Business Overview
  16. 8.3.3 Phalanx Labs Famotidine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Phalanx Labs Famotidine Product Portfolio
  18. 8.3.5 Phalanx Labs Recent Developments
  19. 8.4 PAT IMPEX
  20. 8.4.1 PAT IMPEX Company Information
  21. 8.4.2 PAT IMPEX Business Overview
  22. 8.4.3 PAT IMPEX Famotidine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 PAT IMPEX Famotidine Product Portfolio
  24. 8.4.5 PAT IMPEX Recent Developments
  25. 8.5 Jayusion
  26. 8.5.1 Jayusion Company Information
  27. 8.5.2 Jayusion Business Overview
  28. 8.5.3 Jayusion Famotidine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Jayusion Famotidine Product Portfolio
  30. 8.5.5 Jayusion Recent Developments
  31. 8.6 Gauri Fine Chemicals
  32. 8.6.1 Gauri Fine Chemicals Company Information
  33. 8.6.2 Gauri Fine Chemicals Business Overview
  34. 8.6.3 Gauri Fine Chemicals Famotidine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Gauri Fine Chemicals Famotidine Product Portfolio
  36. 8.6.5 Gauri Fine Chemicals Recent Developments
  37. 8.7 Darou Pakhsh Pharma Chem
  38. 8.7.1 Darou Pakhsh Pharma Chem Company Information
  39. 8.7.2 Darou Pakhsh Pharma Chem Business Overview
  40. 8.7.3 Darou Pakhsh Pharma Chem Famotidine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Darou Pakhsh Pharma Chem Famotidine Product Portfolio
  42. 8.7.5 Darou Pakhsh Pharma Chem Recent Developments
  43. 8.8 Chempro Pharma
  44. 8.8.1 Chempro Pharma Company Information
  45. 8.8.2 Chempro Pharma Business Overview
  46. 8.8.3 Chempro Pharma Famotidine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Chempro Pharma Famotidine Product Portfolio
  48. 8.8.5 Chempro Pharma Recent Developments
9 North America
  1. 9.1 North America Famotidine Market Size by Type
  2. 9.1.1 North America Famotidine Revenue by Type (2021-2032)
  3. 9.1.2 North America Famotidine Sales by Type (2021-2032)
  4. 9.1.3 North America Famotidine Price by Type (2021-2032)
  5. 9.2 North America Famotidine Market Size by Application
  6. 9.2.1 North America Famotidine Revenue by Application (2021-2032)
  7. 9.2.2 North America Famotidine Sales by Application (2021-2032)
  8. 9.2.3 North America Famotidine Price by Application (2021-2032)
  9. 9.3 North America Famotidine Market Size by Country
  10. 9.3.1 North America Famotidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Famotidine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Famotidine Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Famotidine Market Size by Type
  2. 10.1.1 Europe Famotidine Revenue by Type (2021-2032)
  3. 10.1.2 Europe Famotidine Sales by Type (2021-2032)
  4. 10.1.3 Europe Famotidine Price by Type (2021-2032)
  5. 10.2 Europe Famotidine Market Size by Application
  6. 10.2.1 Europe Famotidine Revenue by Application (2021-2032)
  7. 10.2.2 Europe Famotidine Sales by Application (2021-2032)
  8. 10.2.3 Europe Famotidine Price by Application (2021-2032)
  9. 10.3 Europe Famotidine Market Size by Country
  10. 10.3.1 Europe Famotidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Famotidine Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Famotidine Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Famotidine Market Size by Type
  2. 11.1.1 China Famotidine Revenue by Type (2021-2032)
  3. 11.1.2 China Famotidine Sales by Type (2021-2032)
  4. 11.1.3 China Famotidine Price by Type (2021-2032)
  5. 11.2 China Famotidine Market Size by Application
  6. 11.2.1 China Famotidine Revenue by Application (2021-2032)
  7. 11.2.2 China Famotidine Sales by Application (2021-2032)
  8. 11.2.3 China Famotidine Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Famotidine Market Size by Type
  2. 12.1.1 Asia Famotidine Revenue by Type (2021-2032)
  3. 12.1.2 Asia Famotidine Sales by Type (2021-2032)
  4. 12.1.3 Asia Famotidine Price by Type (2021-2032)
  5. 12.2 Asia Famotidine Market Size by Application
  6. 12.2.1 Asia Famotidine Revenue by Application (2021-2032)
  7. 12.2.2 Asia Famotidine Sales by Application (2021-2032)
  8. 12.2.3 Asia Famotidine Price by Application (2021-2032)
  9. 12.3 Asia Famotidine Market Size by Country
  10. 12.3.1 Asia Famotidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Famotidine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Famotidine Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Famotidine Market Size by Type
  2. 13.1.1 SAMEA Famotidine Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Famotidine Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Famotidine Price by Type (2021-2032)
  5. 13.2 SAMEA Famotidine Market Size by Application
  6. 13.2.1 SAMEA Famotidine Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Famotidine Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Famotidine Price by Application (2021-2032)
  9. 13.3 SAMEA Famotidine Market Size by Country
  10. 13.3.1 SAMEA Famotidine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Famotidine Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Famotidine Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Famotidine Value Chain Analysis
  2. 14.1.1 Famotidine Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Famotidine Production Mode & Process
  6. 14.2 Famotidine Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Famotidine Distributors
  9. 14.2.3 Famotidine Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst